Protara Therapeutics, Inc.

Ownership Transactions Reported by 18 Insiders

Symbol
TARA on Nasdaq
Location
345 Park Avenue South, 3 Rd Floor, New York, NY

Insiders trading volume in the past year

Protara Therapeutics, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Jesse Shefferman CEO and President, Director $3.44M Jun 26, 2025
Opaleye Management Inc. 10%+ Owner $3.4M Sep 11, 2024
Jacqueline Zummo Chf Scientific Operations Off $448K -$96.1K -17.7% Mar 26, 2025
Leonardo Nicacio Chief Medical Officer $236K Apr 15, 2025
Patrick Fabbio Chief Financial Officer $202K Jan 24, 2025
William Conkling Chief Commercial Officer $179K Jun 2, 2025
Hannah Fry VP, Controller $175K Jan 24, 2025
Richard S. Levy Director $163K +$63.8K +64.5% Jun 12, 2025
Jathin Bandari Chief Medical Officer $108K Jan 19, 2024
Blaine Davis Chief Financial Officer $39.5K Jul 15, 2022
Martin Sebastian Olivo Chief Medical Officer $27.4K Jun 10, 2021
Gregory Sargen Director Jun 12, 2025
Jane Huang Director Jun 12, 2025
Barry P. Flannelly Director Jun 12, 2025
Michael Edward Solomon Director Jun 12, 2025
Cynthia Smith Director Jun 12, 2025
Luke M. Beshar Director Jun 12, 2025
Roger Garceau Director Jun 12, 2025

Recent Insider Transactions by Companies or Individuals for Protara Therapeutics, Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.